Crown Pharmaceuticals Inc.
Elmwood, LA
- UEI
- MPJ5MEGANEC5
- CAGE
- 6FPD3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 5420 Toler St, Elmwood, LA 70123, USA
- Website
- crownpharma.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 51 Wholesale Trade – Nondurable Goods
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $25,000 |
| FY2025 | $0 |
| FY2024 | $32,250 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Health Agency | $25,000 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Southernbelle Room, LLC | Atlanta, GA | 325412 Pharmaceutical Preparation Manufacturing |
| Avkare LLC | Pulaski, TN | 325412 Pharmaceutical Preparation Manufacturing |
| Tri-Pharma, Inc. | Kennesaw, GA | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Stratus Pharmaceuticals Inc. | Miami, FL | 325412 Pharmaceutical Preparation Manufacturing |
| Fagron Sterile Services | Wichita, KS | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Crown Pharmaceuticals Inc., a woman-owned small business based in Elmwood, Louisiana, supplies secondary pharmaceutical drug supplies and medical materials to federal healthcare facilities as a prime contractor operating entirely on full-and-open competitive awards without set-aside designation.
Crown's customer footprint concentrates on health-sector federal agencies. The Indian Health Service (IHS) accounts for 65% of recent awards by count (13 awards, $1.5 million combined potential value) and maintains the same dominance by dollar rank, followed by the Defense Health Agency (2 awards, $525 thousand), the Department of the Army Medical Command (4 awards, $191 thousand), and the Air Force Air Education and Training Command (1 award, $7 thousand). IHS and Army Medical Command represent established relationships; the source notes Crown has previously held contracts with both agencies to supply pharmaceuticals, medical supplies, and pandemic-related materials to government healthcare facilities.
Crown holds two active BPA vehicles. A single-award Blanket Purchase Agreement with the Defense Health Agency, awarded January 12, 2026, carries a $500 thousand ceiling through January 11, 2031 and covers secondary pharmaceutical drug supplies and related medical materials; a recent April 6, 2026 BPA call against this vehicle valued at $25 thousand demonstrates active task-order placement. A second BPA with IHS (75H71120A00153) has generated five task orders totaling $345 thousand. Representative recent awards include a $32,250 firm fixed-price purchase order from IHS for emergency naltrexone delivery to Alaska Native Medical Center (completed July 19, 2024) and the $25 thousand DHA BPA call for secondary pharmaceutical supplies.
Activity is episodic — two awards in 2019, four in 2020, three in 2021, then a gap until one award in 2024 and two in 2026 — with only $25 thousand in combined potential value completing in the next twenty-four months. Crown operates exclusively as prime (100% of awards), with no subcontract footprint. Work spans pharmaceutical preparation manufacturing and medical/dental/hospital equipment and supplies distribution, with performance locations centered in Oklahoma City and New Orleans alongside Bethesda, Maryland.
Quick answers
Is Crown Pharmaceuticals Inc. registered in SAM.gov?
Yes. Crown Pharmaceuticals Inc.'s SAM.gov registration is active through August 24, 2027.
How much has Crown Pharmaceuticals Inc. received in federal contracts?
Federal contracts obligated $57,250 to Crown Pharmaceuticals Inc. in fiscal years 2023 through 2027.
What is Crown Pharmaceuticals Inc.'s most recent federal award?
Crown Pharmaceuticals Inc.'s most recent federal contract award is Crown pharmaceutical (HT001426FE044), from Defense Health Agency, on April 6, 2026.
On GovTribe
See Crown Pharmaceuticals Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors